| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.908 | 0.003 | 0.908 | Hypolipemic | 0.851 0.004 DBMET03739 0.886 0.003 DBMET03742 0.902 0.003 DBMET03740 0.813 0.004 DBMET03741 | ||
| 0.606 | 0.001 | 0.606 | HMG CoA reductase inhibitor | 0.229 0.001 DBMET03739 0.488 0.001 DBMET03742 0.513 0.001 DBMET03740 0.184 0.001 DBMET03741 | ||
| 0.472 | 0.017 | 0.472 | Platelet antagonist | 0.438 0.021 DBMET03739 0.447 0.02 DBMET03742 0.256 0.07 DBMET03741 | ||
| 0.449 | 0.067 | 0.645 | Cyclophilin D inhibitor | 0.645 0.02 DBMET03739 0.422 0.079 DBMET03742 0.367 0.111 DBMET03741 | DBMET03739 | |
| 0.417 | 0.05 | 0.423 | Vasodilator, peripheral | 0.386 0.06 DBMET03739 0.423 0.048 DBMET03742 0.229 0.145 DBMET03741 | DBMET03742 | |
| 0.328 | 0.004 | 0.328 | Prostaglandin EP2 antagonist | 0.182 0.007 DBMET03739 0.292 0.004 DBMET03742 0.096 0.02 DBMET03741 | ||
| 0.315 | 0.005 | 0.315 | ABCA1 expression enhancer | 0.145 0.019 DBMET03739 0.28 0.005 DBMET03742 0.254 0.006 DBMET03740 0.213 0.008 DBMET03741 | ||
| 0.311 | 0.016 | 0.388 | NOS3 expression enhancer | 0.388 0.009 DBMET03739 0.276 0.022 DBMET03742 0.308 0.017 DBMET03740 0.194 0.043 DBMET03741 | DBMET03739 | |
| 0.329 | 0.067 | 0.415 | Apoptosis antagonist | 0.415 0.034 DBMET03739 0.315 0.076 DBMET03742 0.326 0.068 DBMET03740 0.362 0.05 DBMET03741 | DBMET03739 | |
| 0.333 | 0.071 | 0.626 | Antithrombotic | 0.626 0.014 DBMET03739 0.286 0.098 DBMET03742 | DBMET03739 | |
| 0.275 | 0.014 | 0.318 | Cholesterol synthesis inhibitor | 0.185 0.031 DBMET03739 0.276 0.014 DBMET03742 0.318 0.01 DBMET03740 0.149 0.045 DBMET03741 | DBMET03740 | |
| 0.325 | 0.084 | 0.728 | Transcription factor NF kappa B inhibitor | 0.728 0.018 DBMET03739 0.379 0.068 DBMET03742 0.397 0.064 DBMET03740 0.463 0.05 DBMET03741 | DBMET03739 | |
| 0.243 | 0.003 | 0.243 | Prostaglandin F2 alpha antagonist | 0.13 0.005 DBMET03739 0.208 0.004 DBMET03742 0.103 0.01 DBMET03741 | ||
| 0.368 | 0.16 | 0.702 | Antiinflammatory | 0.702 0.03 DBMET03739 0.367 0.16 DBMET03742 0.332 0.187 DBMET03740 0.544 0.07 DBMET03741 | DBMET03739 | |
| 0.291 | 0.087 | 0.312 | Sodium/bile acid cotransporter inhibitor | 0.312 0.069 DBMET03742 0.266 0.111 DBMET03740 0.282 0.096 DBMET03741 | DBMET03742 | |
| 0.258 | 0.073 | 0.372 | Interleukin agonist | 0.372 0.024 DBMET03739 0.173 0.146 DBMET03742 0.223 0.1 DBMET03741 | DBMET03739 | |
| 0.179 | 0.008 | 0.179 | Prostaglandin antagonist | 0.135 0.012 DBMET03742 0.051 0.039 DBMET03741 | ||
| 0.314 | 0.162 | 0.599 | Apoptosis agonist | 0.599 0.049 DBMET03739 0.356 0.135 DBMET03742 0.522 0.068 DBMET03740 0.515 0.07 DBMET03741 | DBMET03739 | |
| 0.139 | 0.005 | 0.139 | Prostaglandin EP3 antagonist | 0.031 0.02 DBMET03739 0.115 0.005 DBMET03742 0.026 0.025 DBMET03741 | ||
| 0.202 | 0.069 | 0.364 | Non-steroidal antiinflammatory agent | 0.364 0.018 DBMET03739 0.245 0.045 DBMET03742 0.253 0.042 DBMET03741 | DBMET03739 | |
| 0.156 | 0.027 | 0.172 | Photosensitizer | 0.172 0.02 DBMET03739 0.135 0.042 DBMET03742 0.144 0.035 DBMET03740 0.171 0.021 DBMET03741 | DBMET03739 | |
| 0.129 | 0.006 | 0.129 | Thromboxane antagonist | 0.114 0.008 DBMET03742 0.066 0.028 DBMET03741 | ||
| 0.242 | 0.128 | 0.395 | Interleukin 2 agonist | 0.395 0.029 DBMET03739 0.243 0.127 DBMET03742 0.252 0.116 DBMET03740 0.232 0.14 DBMET03741 | DBMET03739 | |
| 0.21 | 0.101 | 0.425 | Tumour necrosis factor alpha release inhibitor | 0.425 0.023 DBMET03739 0.211 0.099 DBMET03742 0.272 0.065 DBMET03740 0.338 0.041 DBMET03741 | DBMET03739 | |
| 0.183 | 0.077 | 0.363 | Hepatoprotectant | 0.363 0.017 DBMET03739 0.194 0.069 DBMET03742 0.2 0.065 DBMET03740 0.275 0.037 DBMET03741 | DBMET03739 | |
| 0.111 | 0.005 | 0.111 | Thromboxane A2 antagonist | 0.101 0.007 DBMET03742 0.062 0.027 DBMET03741 | ||
| 0.175 | 0.076 | 0.203 | Lipocortins synthesis antagonist | 0.162 0.089 DBMET03742 0.167 0.084 DBMET03740 0.203 0.054 DBMET03741 | DBMET03741 | |
| 0.162 | 0.064 | 0.271 | Interferon gamma antagonist | 0.271 0.025 DBMET03739 0.166 0.06 DBMET03742 0.169 0.058 DBMET03740 | DBMET03739 | |
| 0.098 | 0.005 | 0.098 | Prostaglandin agonist | 0.076 0.007 DBMET03742 0.061 0.008 DBMET03741 | ||
| 0.101 | 0.008 | 0.105 | Nitric oxide donor | 0.105 0.006 DBMET03739 0.097 0.01 DBMET03742 0.061 0.046 DBMET03740 0.071 0.032 DBMET03741 | DBMET03739 | |
| 0.194 | 0.109 | 0.334 | Vasodilator | 0.334 0.038 DBMET03739 0.205 0.101 DBMET03742 | DBMET03739 | |
| 0.103 | 0.021 | 0.103 | Leukotriene antagonist | 0.065 0.044 DBMET03739 0.087 0.028 DBMET03742 0.063 0.047 DBMET03741 | ||
| 0.084 | 0.004 | 0.084 | Prostacyclin agonist | 0.034 0.005 DBMET03739 0.071 0.004 DBMET03742 0.024 0.007 DBMET03741 | ||
| 0.176 | 0.101 | 0.176 | Insulin sensitizer | 0.159 0.121 DBMET03742 | ||
| 0.106 | 0.034 | 0.118 | Glutamate release inhibitor | 0.098 0.045 DBMET03739 0.1 0.043 DBMET03742 0.118 0.024 DBMET03741 | DBMET03741 | |
| 0.088 | 0.017 | 0.088 | Prostaglandin E2 antagonist | 0.071 0.023 DBMET03742 | ||
| 0.163 | 0.093 | 0.352 | Platelet adhesion inhibitor | 0.352 0.019 DBMET03739 0.189 0.077 DBMET03742 | DBMET03739 | |
| 0.116 | 0.048 | 0.175 | Toll-Like receptor 4 antagonist | 0.175 0.011 DBMET03739 0.117 0.047 DBMET03742 0.136 0.03 DBMET03741 | DBMET03739 | |
| 0.068 | 0.004 | 0.068 | Prostaglandin EP2 agonist | 0.036 0.01 DBMET03739 0.057 0.005 DBMET03742 0.019 0.018 DBMET03741 | ||
| 0.068 | 0.005 | 0.068 | Prostaglandin E2 agonist | 0.046 0.006 DBMET03742 0.037 0.008 DBMET03741 | ||
| 0.095 | 0.033 | 0.105 | Thioredoxin reductase inhibitor | 0.09 0.041 DBMET03739 0.091 0.039 DBMET03742 0.105 0.025 DBMET03740 0.105 0.025 DBMET03741 | DBMET03741 | |
| 0.134 | 0.073 | 0.134 | Bone formation stimulant | 0.126 0.08 DBMET03739 0.134 0.073 DBMET03742 | ||
| 0.066 | 0.004 | 0.066 | Prostaglandin D2 agonist | 0.043 0.01 DBMET03739 0.061 0.005 DBMET03742 0.035 0.017 DBMET03741 | ||
| 0.19 | 0.131 | 0.218 | 5 Hydroxytryptamine release stimulant | 0.218 0.107 DBMET03741 | DBMET03741 | |
| 0.107 | 0.053 | 0.107 | Folate antagonist | 0.091 0.086 DBMET03742 | ||
| 0.166 | 0.113 | 0.477 | Angiogenesis stimulant | 0.477 0.013 DBMET03739 0.172 0.109 DBMET03742 | DBMET03739 | |
| 0.128 | 0.078 | 0.244 | Interleukin 1 antagonist | 0.111 0.102 DBMET03742 0.244 0.02 DBMET03741 | DBMET03741 | |
| 0.137 | 0.089 | 0.173 | Insulin secretagoues | 0.173 0.053 DBMET03739 | DBMET03739 | |
| 0.151 | 0.103 | 0.168 | Catenin beta inhibitor | 0.141 0.128 DBMET03742 0.168 0.07 DBMET03741 | DBMET03741 | |
| 0.138 | 0.091 | 0.162 | MAP kinase kinase 4 inhibitor | 0.142 0.08 DBMET03742 0.162 0.043 DBMET03740 0.134 0.101 DBMET03741 | DBMET03740 | |
| 0.217 | 0.179 | 0.456 | Immunosuppressant | 0.456 0.045 DBMET03739 0.2 0.197 DBMET03742 0.397 0.064 DBMET03740 0.338 0.093 DBMET03741 | DBMET03739 | |
| 0.083 | 0.046 | 0.106 | Catalase inhibitor | 0.106 0.037 DBMET03741 | DBMET03741 | |
| 0.14 | 0.105 | 0.341 | Nitric oxide antagonist | 0.341 0.033 DBMET03739 0.157 0.089 DBMET03742 0.18 0.076 DBMET03740 0.237 0.055 DBMET03741 | DBMET03739 | |
| 0.108 | 0.073 | 0.17 | Interleukin 1b antagonist | 0.17 0.028 DBMET03741 | DBMET03741 | |
| 0.059 | 0.027 | 0.08 | Aconitate hydratase inhibitor | 0.08 0.014 DBMET03741 | DBMET03741 | |
| 0.059 | 0.029 | 0.059 | Leukotriene B4 antagonist | 0.051 0.043 DBMET03739 0.056 0.033 DBMET03742 0.051 0.042 DBMET03741 | ||
| 0.037 | 0.012 | 0.037 | Prostaglandin EP4 antagonist | 0.033 0.013 DBMET03742 | ||
| 0.06 | 0.04 | 0.062 | Cathepsin E inhibitor | 0.056 0.046 DBMET03742 0.062 0.038 DBMET03741 | DBMET03741 | |
| 0.039 | 0.019 | 0.039 | Prostacyclin antagonist | 0.03 0.025 DBMET03742 | ||
| 0.029 | 0.009 | 0.031 | Prostaglandin F2 alpha agonist | 0.031 0.008 DBMET03742 0.029 0.009 DBMET03741 | DBMET03742 | |
| 0.144 | 0.127 | 0.192 | P-glycoprotein inhibitor | 0.169 0.091 DBMET03739 0.139 0.135 DBMET03742 0.192 0.069 DBMET03741 | DBMET03741 | |
| 0.031 | 0.017 | 0.031 | Leukotriene B4 receptor 1 antagonist | 0.027 0.02 DBMET03742 | ||
| 0.045 | 0.031 | 0.065 | Parathyroid hormone antagonist | 0.065 0.009 DBMET03740 0.043 0.038 DBMET03741 | DBMET03740 | |
| 0.235 | 0.222 | 0.253 | Calcium channel L-type activator | 0.253 0.202 DBMET03742 0.231 0.228 DBMET03741 | DBMET03742 | |
| 0.063 | 0.051 | 0.078 | Leukotriene synthesis inhibitor | 0.078 0.039 DBMET03742 | DBMET03742 | |
| 0.055 | 0.043 | 0.06 | Leukotriene C antagonist | 0.06 0.028 DBMET03741 | DBMET03741 | |
| 0.022 | 0.013 | 0.022 | Prostaglandin EP1 antagonist | |||
| 0.063 | 0.055 | 0.063 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.037 | 0.031 | 0.037 | GABA uptake inhibitor | |||
| 0.022 | 0.016 | 0.022 | Leukotriene B4 receptor 2 antagonist | 0.022 0.016 DBMET03742 | ||
| 0.016 | 0.01 | 0.016 | Thromboxane A2 agonist | |||
| 0.147 | 0.143 | 0.259 | Neurotrophic factor enhancer | 0.259 0.034 DBMET03740 0.154 0.132 DBMET03741 | DBMET03740 | |
| 0.062 | 0.063 | 0.143 | HIV-1 integrase inhibitor | 0.104 0.023 DBMET03742 0.143 0.009 DBMET03741 | DBMET03741 | |
| 0.035 | 0.042 | 0.039 | Leukotriene C4 antagonist | 0.039 0.028 DBMET03741 | DBMET03741 | |
| 0.078 | 0.085 | 0.087 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.087 0.069 DBMET03741 | DBMET03741 | |
| 0.119 | 0.127 | 0.125 | Adenylate cyclase stimulant | 0.125 0.113 DBMET03742 | DBMET03742 | |
| 0.023 | 0.032 | 0.036 | Toll-Like receptor 4 agonist | 0.036 0.006 DBMET03739 | DBMET03739 | |
| 0.126 | 0.141 | 0.236 | Interleukin antagonist | 0.236 0.067 DBMET03741 | DBMET03741 | |
| 0.149 | 0.166 | 0.452 | Antioxidant | 0.452 0.026 DBMET03739 0.231 0.095 DBMET03742 0.2 0.113 DBMET03740 0.3 0.062 DBMET03741 | DBMET03739 | |
| 0.121 | 0.145 | 0.163 | Interleukin 6 antagonist | 0.149 0.09 DBMET03739 0.163 0.071 DBMET03740 | DBMET03740 | |
| 0.13 | 0.156 | 0.141 | Succinate dehydrogenase inhibitor | 0.141 0.13 DBMET03741 | DBMET03741 | |
| 0.129 | 0.157 | 0.145 | Phospholipase C inhibitor | 0.145 0.117 DBMET03741 | DBMET03741 | |
| 0.115 | 0.146 | 0.152 | Melanin inhibitor | 0.152 0.079 DBMET03739 0.134 0.107 DBMET03742 | DBMET03739 | |
| 0.049 | 0.082 | 0.06 | Caspase 9 inhibitor | 0.06 0.048 DBMET03741 | DBMET03741 | |
| 0.051 | 0.084 | 0.062 | Heme oxygenase stimulant | 0.062 0.042 DBMET03740 | DBMET03740 | |
| 0.055 | 0.093 | 0.08 | CDC25A inhibitor | 0.067 0.063 DBMET03742 0.08 0.044 DBMET03740 | DBMET03740 | |
| 0.122 | 0.163 | 0.205 | ATPase inhibitor | 0.204 0.034 DBMET03739 0.205 0.033 DBMET03740 | DBMET03740 | |
| 0.048 | 0.09 | 0.087 | Na+ K+ transporting ATPase inhibitor | 0.087 0.043 DBMET03739 0.087 0.043 DBMET03740 | DBMET03740 | |
| 0.058 | 0.105 | 0.091 | Glycine receptor antagonist | 0.084 0.051 DBMET03739 0.091 0.042 DBMET03740 | DBMET03740 | |
| 0.041 | 0.099 | 0.088 | Phenylalanine 4-hydroxylase inhibitor | 0.088 0.032 DBMET03742 | DBMET03742 | |
| 0.079 | 0.141 | 0.15 | TRPA1 agonist | 0.15 0.031 DBMET03741 | DBMET03741 | |
| 0.04 | 0.104 | 0.149 | Transcription factor AP-1 inhibitor | 0.149 0.006 DBMET03741 | DBMET03741 | |
| 0.071 | 0.135 | 0.181 | AMP-activated protein kinase stimulant | 0.181 0.014 DBMET03739 | DBMET03739 | |
| 0.138 | 0.203 | 0.377 | Hypoglycemic | 0.377 0.032 DBMET03739 0.167 0.152 DBMET03741 | DBMET03739 | |
| 0.121 | 0.186 | 0.436 | Immunostimulant | 0.436 0.04 DBMET03739 0.185 0.13 DBMET03741 | DBMET03739 | |
| 0.177 | 0.243 | 0.227 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.227 0.102 DBMET03740 | DBMET03740 | |
| 0.044 | 0.111 | 0.087 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.087 0.045 DBMET03742 | DBMET03742 | |
| 0.152 | 0.22 | 0.303 | Cholesterol antagonist | 0.303 0.089 DBMET03739 | DBMET03739 | |
| 0.055 | 0.125 | 0.085 | Cell adhesion molecule inhibitor | 0.085 0.047 DBMET03739 | DBMET03739 | |
| 0.063 | 0.137 | 0.165 | Topoisomerase II inhibitor | 0.165 0.043 DBMET03739 0.103 0.084 DBMET03742 0.121 0.066 DBMET03740 0.143 0.053 DBMET03741 | DBMET03739 | |
| 0.077 | 0.151 | 0.117 | Aldehyde dehydrogenase inhibitor | 0.117 0.074 DBMET03741 | DBMET03741 | |
| 0.029 | 0.104 | 0.102 | HIV-1 integrase (Strand Transfer) inhibitor | 0.061 0.041 DBMET03742 0.102 0.022 DBMET03741 | DBMET03741 | |
| 0.054 | 0.129 | 0.111 | Antineoplastic alkaloid | 0.111 0.041 DBMET03740 | DBMET03740 | |
| 0.061 | 0.144 | 0.105 | Transcription factor NF kappa B stimulant | 0.105 0.035 DBMET03739 | DBMET03739 | |
| 0.008 | 0.094 | 0.032 | RNA-directed RNA polymerase stimulant | 0.032 0.02 DBMET03740 | DBMET03740 | |
| 0.043 | 0.129 | 0.062 | Lipocortins synthesis agonist | 0.062 0.032 DBMET03739 | DBMET03739 | |
| 0.033 | 0.123 | 0.073 | HIV-1 integrase (3'-Processing) inhibitor | 0.06 0.047 DBMET03742 0.073 0.037 DBMET03741 | DBMET03741 | |
| 0.057 | 0.149 | 0.123 | ATPase (Vacuolar H+) inhibitor | 0.09 0.057 DBMET03739 0.123 0.017 DBMET03740 | DBMET03740 | |
| 0.068 | 0.161 | 0.192 | Microtubule formation inhibitor | 0.126 0.054 DBMET03739 0.192 0.022 DBMET03740 | DBMET03740 | |
| 0.063 | 0.156 | 0.141 | Vanilloid agonist | 0.141 0.012 DBMET03741 | DBMET03741 | |
| 0.091 | 0.186 | 0.144 | Vanilloid 1 agonist | 0.144 0.045 DBMET03741 | DBMET03741 | |
| 0.053 | 0.148 | 0.087 | HIV-1 integrase (Overall Integration) inhibitor | 0.087 0.069 DBMET03741 | DBMET03741 | |
| 0.024 | 0.123 | 0.069 | Microtubule stabilization | 0.044 0.035 DBMET03739 0.069 0.007 DBMET03740 | DBMET03740 | |
| 0.041 | 0.143 | 0.061 | Potassium channel large-conductance Ca-activated activator | 0.061 0.057 DBMET03742 | DBMET03742 | |
| 0.012 | 0.12 | 0.037 | Farnesoid X receptor agonist | 0.037 0.027 DBMET03740 | DBMET03740 | |
| 0.027 | 0.139 | 0.126 | Antineoplastic antibiotic | 0.126 0.037 DBMET03739 0.104 0.044 DBMET03740 | DBMET03739 | |
| 0.056 | 0.169 | 0.091 | Anabolic | 0.091 0.076 DBMET03740 | DBMET03740 | |
| 0.023 | 0.137 | 0.033 | Calcium-independent phospholipase A2 inhibitor | 0.033 0.026 DBMET03741 | DBMET03741 | |
| 0.072 | 0.187 | 0.136 | Cell adhesion inhibitor | 0.136 0.055 DBMET03739 | DBMET03739 | |
| 0.002 | 0.118 | 0.013 | Antibiotic Macrolide-like | 0.013 0.011 DBMET03740 | DBMET03740 | |
| 0.13 | 0.252 | 0.245 | DNA synthesis inhibitor | 0.217 0.099 DBMET03739 0.245 0.07 DBMET03740 | DBMET03740 | |
| 0.042 | 0.165 | 0.193 | Topoisomerase I inhibitor | 0.193 0.028 DBMET03739 0.134 0.048 DBMET03740 | DBMET03739 | |
| 0.037 | 0.16 | 0.073 | Adenine nucleotide translocase inhibitor | 0.073 0.013 DBMET03739 | DBMET03739 | |
| 0.198 | 0.323 | 0.432 | Caspase 9 stimulant | 0.363 0.135 DBMET03739 0.432 0.093 DBMET03740 | DBMET03740 | |
| 0.031 | 0.173 | 0.068 | Sirtuin 1 inhibitor | 0.068 0.047 DBMET03741 | DBMET03741 | |
| 0.053 | 0.198 | 0.154 | Amylase inhibitor | 0.154 0.062 DBMET03739 | DBMET03739 | |
| 0.051 | 0.202 | 0.105 | Thioredoxin inhibitor | 0.105 0.043 DBMET03741 | DBMET03741 | |
| 0.026 | 0.181 | 0.061 | Heparanase inhibitor | 0.061 0.022 DBMET03739 | DBMET03739 | |
| 0.062 | 0.238 | 0.118 | Neurotrophic factor | 0.118 0.099 DBMET03741 | DBMET03741 | |
| 0.068 | 0.245 | 0.128 | Phospholipase A2 inhibitor | 0.128 0.104 DBMET03741 | DBMET03741 | |
| 0.028 | 0.207 | 0.142 | Topoisomerase II alpha inhibitor | 0.087 0.048 DBMET03739 0.142 0.024 DBMET03741 | DBMET03741 | |
| 0.017 | 0.202 | 0.089 | Protein 50S ribosomal subunit inhibitor | 0.073 0.023 DBMET03739 0.089 0.016 DBMET03740 | DBMET03740 | |
| 0.055 | 0.241 | 0.109 | Phosphodiesterase 6D inhibitor | 0.109 0.037 DBMET03741 | DBMET03741 | |
| 0.05 | 0.238 | 0.173 | Thrombolytic | 0.173 0.066 DBMET03739 | DBMET03739 | |
| 0.079 | 0.277 | 0.363 | Free radical scavenger | 0.363 0.036 DBMET03739 0.162 0.132 DBMET03742 0.315 0.048 DBMET03741 | DBMET03739 | |
| 0.044 | 0.253 | 0.112 | DNA polymerase I inhibitor | 0.112 0.074 DBMET03740 0.096 0.091 DBMET03741 | DBMET03740 | |
| 0.016 | 0.232 | 0.084 | Tubulin agonist | 0.084 0.003 DBMET03740 | DBMET03740 | |
| 0.045 | 0.265 | 0.107 | Beta amyloid protein antagonist | 0.107 0.081 DBMET03739 | DBMET03739 | |
| 0.016 | 0.245 | 0.23 | Selectin antagonist | 0.23 0.009 DBMET03739 | DBMET03739 | |
| 0.113 | 0.351 | 0.227 | Toll-Like receptor agonist | 0.227 0.171 DBMET03742 | DBMET03742 | |
| 0.059 | 0.321 | 0.149 | DNA methyltransferase I inhibitor | 0.149 0.105 DBMET03741 | DBMET03741 | |
| 0.02 | 0.283 | 0.104 | Glucose-6-phosphate translocase inhibitor | 0.056 0.028 DBMET03739 0.104 0.005 DBMET03741 | DBMET03741 | |
| 0.064 | 0.332 | 0.167 | Hemostatic | 0.167 0.051 DBMET03739 | DBMET03739 | |
| 0.1 | 0.389 | 0.208 | Toll-Like receptor 7 agonist | 0.208 0.191 DBMET03742 | DBMET03742 | |
| 0.045 | 0.334 | 0.134 | Protein kinase stimulant | 0.134 0.08 DBMET03740 | DBMET03740 | |
| 0.057 | 0.346 | 0.178 | Antiamyloidogenic | 0.178 0.116 DBMET03739 | DBMET03739 | |
| 0.105 | 0.394 | 0.284 | Peptidyltransferase inhibitor | 0.284 0.031 DBMET03739 0.175 0.137 DBMET03740 | DBMET03739 | |
| 0.043 | 0.334 | 0.182 | Amyloid beta aggregation inhibitor | 0.153 0.106 DBMET03742 0.182 0.088 DBMET03741 | DBMET03741 | |
| 0.014 | 0.342 | 0.049 | Antibiotic Aminoglycoside-like | 0.049 0.014 DBMET03739 | DBMET03739 | |
| 0.073 | 0.403 | 0.199 | Transcription factor STAT inhibitor | 0.199 0.14 DBMET03741 | DBMET03741 | |
| 0.03 | 0.378 | 0.166 | Lipid peroxidase inhibitor | 0.166 0.058 DBMET03739 | DBMET03739 | |
| 0.083 | 0.439 | 0.54 | Antibacterial | 0.54 0.031 DBMET03739 0.42 0.068 DBMET03740 | DBMET03739 | |
| 0.088 | 0.471 | 0.407 | Caspase 3 stimulant | 0.407 0.043 DBMET03740 | DBMET03740 | |
| 0.024 | 0.435 | 0.098 | Multidrug resistance-associated protein 1 inhibitor | 0.098 0.081 DBMET03739 | DBMET03739 | |
| 0.023 | 0.453 | 0.096 | Beta glucuronidase inhibitor | 0.096 0.077 DBMET03739 0.095 0.078 DBMET03740 | DBMET03739 | |
| 0.031 | 0.48 | 0.435 | Antimitotic | 0.435 0.019 DBMET03740 | DBMET03740 | |
| 0.061 | 0.51 | 0.154 | Growth factor agonist | 0.154 0.133 DBMET03740 | DBMET03740 | |
| 0.039 | 0.534 | 0.133 | Interleukin 2 antagonist | 0.133 0.029 DBMET03740 | DBMET03740 | |
| 0.054 | 0.558 | 0.263 | Immunomodulator | 0.263 0.105 DBMET03739 | DBMET03739 | |
| 0.069 | 0.69 | 0.122 | CC chemokine 6 receptor antagonist | 0.122 0.104 DBMET03739 | DBMET03739 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |